• OPEN AN ACCOUNT
Indian Indices
Sensex
71,593.24 -1,045.46
( -1.44%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
69,343.08 -692.63
(-0.99%)
Nikkei 225
10,441.54 -16.96
(-0.16%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Parmax Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540359
INE240T01014
6.6792598
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
95.69
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Ion Exchange (India) consolidated net profit declines 61.89% in the March 2026 quarter
May 27,2026
Net profit of Ion Exchange (India) declined 61.89% to Rs 24.14 crore in the quarter ended March 2026 as against Rs 63.35 crore during the previous quarter ended March 2025. Sales rose 3.44% to Rs 863.27 crore in the quarter ended March 2026 as against Rs 834.56 crore during the previous quarter ended March 2025.

For the full year,net profit declined 31.35% to Rs 142.67 crore in the year ended March 2026 as against Rs 207.81 crore during the previous year ended March 2025. Sales rose 6.49% to Rs 2914.84 crore in the year ended March 2026 as against Rs 2737.11 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales863.27834.56 3 2914.842737.11 6
OPM %2.2910.27 -7.2110.73 -
PBDT52.0096.97 -46 274.43329.97 -17
PBT32.4085.14 -62 211.83285.48 -26
NP24.1463.35 -62 142.67207.81 -31